ロード中...
Identification of LAMC2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. While the extracellular matrix (ECM) components plays an integral role in PDAC pathogenesis and mediating chemoresistance, its role in predicting response to chemotherapy in PDAC patients remains unclear. MET...
保存先:
| 出版年: | Eur J Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7940597/ https://ncbi.nlm.nih.gov/pubmed/33607476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2020.12.031 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|